Home > Insider Trading > Filing (0001209191-15-008075)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1158895	Lemaitre Vascular Inc	LMAT	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1365741	R Peter Gebauer	C/O Lemaitre Vascular, Inc. 63 Second Avenue Burlington MA 01803	President, International Op	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-01-28	4,094	$0.10	45,960	No	4	M	Direct
Common Stock	Disposition	2015-01-28	4,094	$7.91	41,866	No	4	S	Direct
Common Stock	Acquisiton	2015-01-29	12,825	$0.10	54,691	No	4	M	Direct
Common Stock	Disposition	2015-01-29	12,825	$7.91	41,866	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2015-01-28	4,094	$0.00	4,094	$0.10
Common Stock	Stock Option (Right to Buy)	Disposition	2015-01-29	12,825	$0.00	12,825	$0.10

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
186,295	1997-06-02	2007-06-02	No	4	M	Direct
173,470	1997-06-02	2007-06-02	No	4	M	Direct

Footnotes

Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
This transaction was effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $7.90 to $7.94. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $7.90 to $7.95. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
This option is fully vested and exercisable.
This stock option was originally reported on Form 3 as having an expiration date of June 2, 2007, but does not in fact have an expiration date. Because an expiration date is required to be reported, the originally reported expiration date is included for the sake of consistency.